Search research articles
Contact Us
Filters
Showing results (51-60 of 66) with videos related to
Page
of 7
Sort By:
Journal for Immunotherapy of Cancer
|
December 3, 2020
SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery
Siwen Hu-Lieskovan, Srabani Bhaumik, Kavita Dhodapkar, et al.
The Lancet. Oncology
|
March 14, 2018
Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trial
Toni K Choueiri, James Larkin, Mototsugu Oya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 23, 2024
Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 Cohort 3
Petros Grivas, Damien Pouessel, Chandler H Park, et al.
Clinical Proteomics
|
April 18, 2025
Circulatory prostate cancer proteome landscapes and prognostic biomarkers in metastatic castrate resistant prostate cancer
Hyejung Lee, Jincheng Shen, Muhammad Zaki Fadlullah, et al.
Cancer
|
March 26, 2020
Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA results
Sumanta K Pal, Dean Bajorin, Nazli Dizman, et al.
Cancer
|
December 21, 2018
Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes
Petros Grivas, Amir Mortazavi, Joel Picus, et al.
JCO Precision Oncology
|
July 8, 2024
Inherited Germline Variants in Urinary Tract Cancer: A Multicenter Whole-Exome Sequencing Analysis and Correlation With Clinical Features and Tumor Genomics
Wendy Kohlmann, David A Nix, Kristen Pauley, et al.
NPJ Precision Oncology
|
January 12, 2026
ShinyEvents: harmonizing longitudinal data for real-world survival estimation
Alyssa Obermayer, Joshua Davis, Divya Priyanka Talada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2020
Randomized Double-Blind Phase II Study of Maintenance Pembrolizumab Versus Placebo After First-Line Chemotherapy in Patients With Metastatic Urothelial Cancer
Matthew D Galsky, Amir Mortazavi, Matthew I Milowsky, et al.
Research Square
|
August 13, 2025
ShinyEvents: harmonizing longitudinal data for real world survival estimation
Alyssa Obermayer, Joshua Davis, Divya Priyanka Talada, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 66) with videos related to
Sort By:
Page
of 7
Journal for Immunotherapy of Cancer
|
December 3, 2020
SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery
Siwen Hu-Lieskovan, Srabani Bhaumik, Kavita Dhodapkar, et al.
The Lancet. Oncology
|
March 14, 2018
Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trial
Toni K Choueiri, James Larkin, Mototsugu Oya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 23, 2024
Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 Cohort 3
Petros Grivas, Damien Pouessel, Chandler H Park, et al.
Clinical Proteomics
|
April 18, 2025
Circulatory prostate cancer proteome landscapes and prognostic biomarkers in metastatic castrate resistant prostate cancer
Hyejung Lee, Jincheng Shen, Muhammad Zaki Fadlullah, et al.
Cancer
|
March 26, 2020
Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA results
Sumanta K Pal, Dean Bajorin, Nazli Dizman, et al.
Cancer
|
December 21, 2018
Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes
Petros Grivas, Amir Mortazavi, Joel Picus, et al.
JCO Precision Oncology
|
July 8, 2024
Inherited Germline Variants in Urinary Tract Cancer: A Multicenter Whole-Exome Sequencing Analysis and Correlation With Clinical Features and Tumor Genomics
Wendy Kohlmann, David A Nix, Kristen Pauley, et al.
NPJ Precision Oncology
|
January 12, 2026
ShinyEvents: harmonizing longitudinal data for real-world survival estimation
Alyssa Obermayer, Joshua Davis, Divya Priyanka Talada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2020
Randomized Double-Blind Phase II Study of Maintenance Pembrolizumab Versus Placebo After First-Line Chemotherapy in Patients With Metastatic Urothelial Cancer
Matthew D Galsky, Amir Mortazavi, Matthew I Milowsky, et al.
Research Square
|
August 13, 2025
ShinyEvents: harmonizing longitudinal data for real world survival estimation
Alyssa Obermayer, Joshua Davis, Divya Priyanka Talada, et al.
Page
of 7